FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W33007984> ?p ?o ?g. }

• W33007984 endingPage "29" @default.
• W33007984 startingPage "13" @default.
• W33007984 abstract "Abstract Extensive immunologic surface marker analyses and binding competition assays demonstrated that B43 monoclonal antibody (MoAb) is a new member of the CD19 cluster that recognizes the same surface epitope as several other anti-CD19 MoAbs. We used B43 MoAb to test for CD19 expression on neoplastic cells from 340 leukemia and 151 malignant lymphoma patients and on nonneoplastic cells in normal lymphohematopoietic and nonlymphohematopoietic tissues. Our study more than doubles the total number of cases with classified hematologic malignancies that have been examined for CD19 antigen expression. The data presented confirm that CD19 is the most reliable B lineage surface marker and support our view that this B lineage-restricted surface determinant may be an important functional receptor. Our findings provide unique and direct evidence that (a) CD19 is expressed on leukemic B lineage lymphoid progenitor cells freshly obtained from B lineage acute lymphoblastic leukemia patients but not on normal myeloid, erythroid, megakaryocytic, or multilineage bone marrow progenitor cells; (b) ligation of CD19 with B43 MoAb induces sustained increases in [Ca2+]i when crosslinked and inhibits high-molecular weight B cell growth factor (HMW-BCGF)-induced proliferation of activated B cells without affecting their low- molecular weight B cell growth factor (LMW-BCGF) response; therefore CD19 may be a unique signal receptor; (c) HMW-BCGF and LMW-BCGF augment expression of CD19, which suggests that CD19 and BCGF receptors may be under coordinate regulatory control; (d) approximately two million B43 MoAb molecules per cell can be bound to target B lineage lymphoma cells with a Ka of 1.9 x 10(8)/mol/L; (e) CD19 can undergo B43 MoAb-induced internalization; and (f) the opportunity is thus provided for using anti-CD19 MoAb to deliver toxins to B lineage neoplastic cells for more effective treatment of high-risk leukemia/lymphoma patients." @default.
• W33007984 created "2016-06-24" @default.
• W33007984 creator A5005003478 @default.
• W33007984 creator A5031736334 @default.
• W33007984 creator A5046062964 @default.
• W33007984 creator A5049353510 @default.
• W33007984 creator A5051714527 @default.
• W33007984 creator A5054281421 @default.
• W33007984 creator A5055065582 @default.
• W33007984 creator A5058301639 @default.
• W33007984 creator A5091381226 @default.
• W33007984 creator A5091594458 @default.
• W33007984 date "1988-01-01" @default.
• W33007984 modified "2023-10-15" @default.
• W33007984 title "Detailed studies on expression and function of CD19 surface determinant by using B43 monoclonal antibody and the clinical potential of anti- CD19 immunotoxins" @default.
• W33007984 cites W1484262719 @default.
• W33007984 cites W1508716863 @default.
• W33007984 cites W1516389016 @default.
• W33007984 cites W1527999229 @default.
• W33007984 cites W1543988047 @default.
• W33007984 cites W1548735291 @default.
• W33007984 cites W1558437093 @default.
• W33007984 cites W1559716485 @default.
• W33007984 cites W1563889021 @default.
• W33007984 cites W1571107804 @default.
• W33007984 cites W1574744856 @default.
• W33007984 cites W1606710461 @default.
• W33007984 cites W16233902 @default.
• W33007984 cites W1662473501 @default.
• W33007984 cites W173403278 @default.
• W33007984 cites W1751416796 @default.
• W33007984 cites W1917147955 @default.
• W33007984 cites W1927061416 @default.
• W33007984 cites W1946045377 @default.
• W33007984 cites W1964684722 @default.
• W33007984 cites W1968063260 @default.
• W33007984 cites W1975477730 @default.
• W33007984 cites W1981070246 @default.
• W33007984 cites W1987189799 @default.
• W33007984 cites W1997346710 @default.
• W33007984 cites W2000692697 @default.
• W33007984 cites W2016199229 @default.
• W33007984 cites W2018939247 @default.
• W33007984 cites W2022623654 @default.
• W33007984 cites W2028651992 @default.
• W33007984 cites W2030407167 @default.
• W33007984 cites W2030522563 @default.
• W33007984 cites W2033828661 @default.
• W33007984 cites W2050432242 @default.
• W33007984 cites W2053657535 @default.
• W33007984 cites W2058426435 @default.
• W33007984 cites W2069394950 @default.
• W33007984 cites W2070283605 @default.
• W33007984 cites W2083685306 @default.
• W33007984 cites W2086271423 @default.
• W33007984 cites W2093107928 @default.
• W33007984 cites W2096428903 @default.
• W33007984 cites W2109012349 @default.
• W33007984 cites W2126949185 @default.
• W33007984 cites W2134897499 @default.
• W33007984 cites W2156290488 @default.
• W33007984 cites W2163451755 @default.
• W33007984 cites W2168885796 @default.
• W33007984 cites W2178769189 @default.
• W33007984 cites W235368187 @default.
• W33007984 cites W2411121655 @default.
• W33007984 cites W2413781046 @default.
• W33007984 cites W315872135 @default.
• W33007984 cites W629661748 @default.
• W33007984 doi "https://doi.org/10.1182/blood.v71.1.13.13" @default.
• W33007984 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/3257143" @default.
• W33007984 hasPublicationYear "1988" @default.
• W33007984 type Work @default.
• W33007984 sameAs 33007984 @default.
• W33007984 citedByCount "212" @default.
• W33007984 countsByYear W330079842012 @default.
• W33007984 countsByYear W330079842013 @default.
• W33007984 countsByYear W330079842014 @default.
• W33007984 countsByYear W330079842015 @default.
• W33007984 countsByYear W330079842016 @default.
• W33007984 countsByYear W330079842017 @default.
• W33007984 countsByYear W330079842018 @default.
• W33007984 countsByYear W330079842019 @default.
• W33007984 countsByYear W330079842020 @default.
• W33007984 countsByYear W330079842021 @default.
• W33007984 countsByYear W330079842022 @default.
• W33007984 countsByYear W330079842023 @default.
• W33007984 crossrefType "journal-article" @default.
• W33007984 hasAuthorship W33007984A5005003478 @default.
• W33007984 hasAuthorship W33007984A5031736334 @default.
• W33007984 hasAuthorship W33007984A5046062964 @default.
• W33007984 hasAuthorship W33007984A5049353510 @default.
• W33007984 hasAuthorship W33007984A5051714527 @default.
• W33007984 hasAuthorship W33007984A5054281421 @default.
• W33007984 hasAuthorship W33007984A5055065582 @default.
• W33007984 hasAuthorship W33007984A5058301639 @default.
• W33007984 hasAuthorship W33007984A5091381226 @default.
• W33007984 hasAuthorship W33007984A5091594458 @default.

• next